Latest news
News
NHS Greater Glasgow and Clyde teams up with Glasgow City FC to boost cervical screening uptake
NHS Greater Glasgow and Clyde (NHSGGC) has partnered with Glasgow City Football Club to encourage mo…
News
Mum and son both treated for children’s cancer – three decades on
Stephanie Muirhead and her son, Andrew (14), share a bond strengthened by an experience few families…
News
Glasgow’s safer drug consumption facility records more than 11,000 visits in first year
The UK’s first safer drug consumption facility, known as The Thistle, marked its first year in…
Additional news resources
Contacts for media and journalist enquiries only!
News on social media
Facebook Posts
We’re making it easier to find out more about Primary Care.![]()
![]()
Alongside the full strategy, we’ve published an executive summary and an easy read version, with accessible formats and translations available.![]()
![]()
This makes it easier for more people to find out what Primary Care is and how it supports you and your community.![]()
![]()
Find out more via our Primary Care hub by using the QR code or visiting 👉 www.nhsggc.scot/primarycare
A new heart failure treatment could allow patients to return home days earlier than expected, a UK-wide trial has found. ![]()
![]()
The SUBCUT HF II trial, led by the University of Glasgow and co-sponsored by NHS Greater Glasgow and Clyde, has shown that a wearable mini‑pump and innovative medication can safely help patients continue treatment at home.![]()
![]()
This pioneering approach required new ways of safely managing both the medicine and the device, supported by our Research and Innovation Pharmacy teams.![]()
![]()
Find out more about this trial here: www.nhsggc.scot/innovative-heart-failure-treatment-proves-transformative-for-patients/
Was this helpful?
Thanks for your feedback!